Zacks Research Brokers Raise Earnings Estimates for Amarin
Amarin Co. plc (NASDAQ:AMRN – Free Report) – Research analysts at Zacks Research lifted their Q1 2025 earnings estimates for shares of Amarin in a research report issued to clients and investors on Thursday, April 24th. Zacks Research analyst R. Department now expects that the biopharmaceutical company will earn ($1.23) per share for the quarter, […]
